(Q41235610)

28 September 2017

1 reference

title

Therapeutic horizons for amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

28 September 2017

main subject

0 references

author name string

Rothstein JD

series ordinal

1

1 reference

28 September 2017

publication date

1 October 1996

1 reference

Current Opinion in Neurobiology

28 September 2017

published in

1 reference

28 September 2017

volume

6

1 reference

28 September 2017

issue

5

1 reference

28 September 2017

page(s)

679-687

1 reference

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Superoxide dismutase and familial amyotrophic lateral sclerosis: new insights into mechanisms and treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Excitotoxicity hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Evidence for autoimmunity in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

[3H]d-aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Oxidative damage to protein in sporadic motor neuron disease spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Neuronal growth and death: order and disorder in the axoplasm.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

New pathological findings in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Corpus callosum atrophy in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Requirement for superoxide in excitotoxic cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Role of excitotoxicity in human neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Peroxynitrite inhibits glutamate transporter subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Alternative excitotoxic hypotheses

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Motor neurone disease and animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Ciliary neurotrophic factor prevents retrograde neuronal death in the adult central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Ventral root avulsion: an experimental model of death of adult motor neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Potentiated necrosis of cultured cortical neurons by neurotrophins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Basic fibroblast growth factor protects cerebellar neurons in primary culture from NMDA and non-NMDA receptor mediated neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

A null mutation in the human CNTF gene is not causally related to neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-4388%2896%2980103-6

7 January 2021

10.1016/S0959-4388(96)80103-6

Identifiers

DOI

1 reference

28 September 2017

1 reference